Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Third of the big three US drug distributors, also a medical products manufacturer. GLP-1 sales rose significantly across fiscal 2024 and 2025 and lifted reported revenue, but the company disclosed that they did not meaningfully contribute to segment profit.
All metrics are vertically resized to show how they've changed over time. They're not on the same Y-axis. This chart is meant to compare trends, not values.
Values normalized to 0-100 scale for comparison. Hover for actual values.